LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing the Company has gained CE Mark approval fo…
Author: Business Wire
OptiKira, Leader in Unfolded Protein Response Therapeutics to Present at the BIOTECH SHOWCASE, January 13, 2020
RADNOR, Pa.–(BUSINESS WIRE)– #JPM20–OptiKira, Leader in Unfolded Protein Response Therapeutics to Present at the Biotech Showcase, January 13, 2020
North America Vision Care Market to Generate a Value of US $28.2 Billion by End of Forecast Period, 2019-2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “North America Vision Care Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s offering. The publisher expects the market to reach a value of U…
Haymarket Medical Education Receives Interprofessional Joint Accreditation for the Healthcare Team
PARAMUS, N.J.–(BUSINESS WIRE)– #CME–Caroline O. Pardo, Ph.D., General Manager for Haymarket Medical Education (HME), is pleased to announce that HME, based in Paramus, NJ, has been accredited as a provider of interprofessional continuing education (…
Gemini Therapeutics Enrolls First Patient in Phase 1 Study of GEM103 for Dry Age-related Macular Degeneration
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gemini Therapeutics has enrolled the first patient in its Phase 1 study of GEM103 for dry age-related macular degeneration.
Topical Ocular Formulation of Aerpio Pharmaceutical’s AKB-9778 Product Candidate Produced IOP Lowering with Minimal Hyperemia When Combined with Prostaglandin in Subjects with Primary Open Angle Glaucoma or Ocular Hypertension in Phase 1b Trial
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced new results from the fifth coh…
Kala Pharmaceuticals to Present at 38th Annual J.P. Morgan Healthcare Conference
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Delivery Tec…
Eyevensys Closes $30M Series B Financing
PARIS & FORT WORTH, Texas–(BUSINESS WIRE)– #Finance–Eyevensys developing non-viral gene therapies for retinal and other ophthalmic diseases, announces that it has completed a $30M Series B financing.
Midwest Vision Partners Announces Partnership With Michigan Eye Institute
CHICAGO & FLINT, Mich.–(BUSINESS WIRE)–Midwest Vision Partners (“MVP”) is pleased to announce its partnership with Michigan Eye Institute (“MEI”). This represents MVP’s first partnership in Michigan. MVP is a people-focused eye care management servic…
Aura Biosciences Appoints George Golumbeski, Ph.D., as Chairman of the Board of Directors
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a clinical-stage biopharmaceutical company developing a new class of tumor targeted therapies for initial application in primary tumors such as ocular and bladder cancers, today announced the appoint…
Stanton Optical, Leading Eye Care Provider, Opens Sacramento Area Location
SACRAMENTO, Calif.–(BUSINESS WIRE)– #California–Stanton Optical, a retail brand of Now Optics – a leading eye care provider – opened a new store in Florin, California, at 420 Florin Rd.
Acucela Announces Publication Assessing the Role of Emixustat Hydrochloride in Retinal Degeneration Treatment
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the publication of an article concerning the company’s inve…
Global Ophthalmology Devices Market 2019-2023| Evolving Opportunities with Alcon Inc. and Bausch Health Companies Inc. | Technavio
LONDON–(BUSINESS WIRE)– #HealthcareDevices–Global ophthalmology devices market is poised to grow by USD 13.9 billion during 2019-2023, progressing at a CAGR of close to 4%.
ProtoKinetix AAGP® Dry Eye Therapy Testing Results
MARIETTA, Ohio–(BUSINESS WIRE)– #AAGP–ProtoKinetix AAGP® Dry Eye Therapy Testing Results
Alnylam to Webcast Presentation at 38th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the 38th Annual J.P. Morgan Healthcare Conference on Monday, Janu…
PhotoniCare Announces FDA Clearance for First-In-Class Technology for Imaging the Ear
CHAMPAIGN, Ill.–(BUSINESS WIRE)–PhotoniCare, Inc., a company dedicated to revolutionizing healthcare by providing physicians with better diagnostic tools, today announced that the U.S. Food & Drug Administration (FDA) has granted 510(k) clearance…
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …
Uveitis Market Pipeline Review & Analysis, H2 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Uveitis – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Report Highlights The Publisher’s Pharmaceutical and Healthcare latest pipeline guide Uveitis – Pipeline Review, H2 20…
OTITOPIC™ Announces Results of Dose-Finding PK/PD Study for ASPRIHALE® Dry Powder Inhalation of Aspirin for Acute Myocardial Infarction (MI)
LOS ANGELES–(BUSINESS WIRE)–OTITOPIC™ Announces Results of Dose-Finding PK/PD Study for ASPRIHALE® Dry Powder Inhalation of Aspirin for Acute Myocardial Infarction (MI)
North America Dry Eye Syndrome Market by Disease Type, Drug Type, Product, Distribution Channel and Region – Forecast to 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “North America Dry Eye Syndrome Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s offering. The North America dry eye syndrome market reached…